Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101


Randomized controlled trial of Hepatitis B virus vaccine in HIV-1-infected patients comparing two different doses.

Cornejo-Juárez P, Volkow-Fernández P, Escobedo-López K, Vilar-Compte D, Ruiz-Palacios G, Soto-Ramírez LE.

AIDS Res Ther. 2006 Apr 6;3:9. doi: 10.1186/1742-6405-3-9.


Randomized trial of recombinant hepatitis B vaccine in HIV-infected adult patients comparing a standard dose to a double dose.

Fonseca MO, Pang LW, de Paula Cavalheiro N, Barone AA, Heloisa Lopes M.

Vaccine. 2005 Apr 22;23(22):2902-8.


Vaccination against hepatitis B with 4-double doses increases response rates and antibodies titers in HIV-infected adults.

Potsch DV, Camacho LA, Tuboi S, Villar LM, Miguel JC, Ginuíno C, Silva EF, Mendonça RM, Moreira RB, Barroso PF.

Vaccine. 2012 Sep 7;30(41):5973-7. doi: 10.1016/j.vaccine.2012.07.028. Epub 2012 Jul 21.


Serological response to one intradermal or intramuscular hepatitis B virus vaccine booster dose in human immunodeficiency virus-infected nonresponders to standard vaccination.

Ramezani A, Janbakhsh A, Gol-Mohammadi M, Banifazl M, Aghakhani A, Eslamifar A, Pournasiri Z, Mahdavian B, Farazi AA, Sofian M.

Perspect Clin Res. 2014 Jul;5(3):134-8. doi: 10.4103/2229-3485.134318.


Safety and immunogenicity of 4 intramuscular double doses and 4 intradermal low doses vs standard hepatitis B vaccine regimen in adults with HIV-1: a randomized controlled trial.

Launay O, van der Vliet D, Rosenberg AR, Michel ML, Piroth L, Rey D, Colin de Verdière N, Slama L, Martin K, Lortholary O, Carrat F; ANRS HB03 VIHVAC-B Trial.

JAMA. 2011 Apr 13;305(14):1432-40. doi: 10.1001/jama.2011.351.


Immune responses in patients with HIV infection after vaccination with recombinant Hepatitis B virus vaccine.

Pasricha N, Datta U, Chawla Y, Singh S, Arora SK, Sud A, Minz RW, Saikia B, Singh H, James I, Sehgal S.

BMC Infect Dis. 2006 Mar 30;6:65.


Hepatitis B vaccine responsiveness and clinical outcomes in HIV controllers.

Okulicz JF, Mesner O, Ganesan A, O'Bryan TA, Deiss RG, Agan BK.

PLoS One. 2014 Aug 21;9(8):e105591. doi: 10.1371/journal.pone.0105591. eCollection 2014.


[Efficacy of vaccination against hepatitis B in adult with HIV infection].

Kalinowska-Nowak A, Bociaga-Jasik M, Garlicki A, Mach T.

Przegl Epidemiol. 2007;61(2):339-47. Polish.


Does increased hepatitis B vaccination dose lead to a better immune response in HIV-infected patients than standard dose vaccination: a meta-analysis?

Ni JD, Xiong YZ, Wang XJ, Xiu LC.

Int J STD AIDS. 2013 Feb;24(2):117-22. doi: 10.1177/0956462412472309. Epub 2013 May 6. Review.


Prevalence of hepatitis B and C seropositivity in a Nigerian cohort of HIV-infected patients.

Otegbayo JA, Taiwo BO, Akingbola TS, Odaibo GN, Adedapo KS, Penugonda S, Adewole IF, Olaleye DO, Murphy R, Kanki P.

Ann Hepatol. 2008 Apr-Jun;7(2):152-6.


Hepatitis B vaccine responses in a large U.S. military cohort of HIV-infected individuals: another benefit of HAART in those with preserved CD4 count.

Landrum ML, Huppler Hullsiek K, Ganesan A, Weintrob AC, Crum-Cianflone NF, Barthel RV, Peel S, Agan BK.

Vaccine. 2009 Jul 23;27(34):4731-8. doi: 10.1016/j.vaccine.2009.04.016. Epub 2009 May 3.


Comparative effectiveness of two doses versus three doses of hepatitis A vaccine in human immunodeficiency virus-infected and -uninfected men who have sex with men.

Tseng YT, Chang SY, Liu WC, Sun HY, Wu CH, Wu PY, Lu CL, Hung CC, Chang SC.

Hepatology. 2013 May;57(5):1734-41. doi: 10.1002/hep.26210. Epub 2013 Mar 14.


Association between hepatitis B vaccine antibody response and CD4 reconstitution after initiation of combination antiretroviral therapy in HIV-infected persons.

Allen K, Mesner O, Ganesan A, O'Bryan TA, Deiss RG, Agan BK, Okulicz JF.

BMC Infect Dis. 2015 May 1;15:203. doi: 10.1186/s12879-015-0937-5.


Hepatitis A and B immunizations of individuals infected with human immunodeficiency virus.

Laurence JC.

Am J Med. 2005 Oct;118 Suppl 10A:75S-83S. Review.


Hepatitis B vaccination uptake and correlates of serologic response among HIV-infected and uninfected men who have sex with men (MSM) in Bangkok, Thailand.

Chonwattana W, Raengsakulrach B, Holtz TH, Wasinrapee P, Tongtoyai J, Chaikummao S, Pattanasin S, McNicholl JM, van Griensven F, Curlin ME.

Vaccine. 2016 Apr 12;34(17):2044-50. doi: 10.1016/j.vaccine.2015.11.071. Epub 2015 Dec 10.


CD4/CD8 ratio as a predictor of the response to HBV vaccination in HIV-positive patients: A prospective cohort study.

Fuster F, Vargas JI, Jensen D, Sarmiento V, Acuña P, Peirano F, Fuster F, Arab JP, Martínez F; Core-HIV Study Group.

Vaccine. 2016 Apr 7;34(16):1889-95. doi: 10.1016/j.vaccine.2016.02.055. Epub 2016 Mar 2.


HIV viraemia during hepatitis B vaccination shortens the duration of protective antibody levels.

O'Bryan TA, Rini EA, Okulicz J, Messner O, Ganesan A, Lalani T, Bavaro MF, O'Connell RJ, Agan BK, Landrum ML.

HIV Med. 2015 Mar;16(3):161-7. doi: 10.1111/hiv.12189. Epub 2015 Jan 14.


Hepatitis B vaccine antibody response and the risk of clinical AIDS or death.

Landrum ML, Hullsiek KH, O'Connell RJ, Chun HM, Ganesan A, Okulicz JF, Lalani T, Weintrob AC, Crum-Cianflone NF, Agan BK; Infectious Disease Clinical Research Program HIV Working Group.

PLoS One. 2012;7(3):e33488. doi: 10.1371/journal.pone.0033488. Epub 2012 Mar 22.


Increasing the number of hepatitis B vaccine injections augments anti-HBs response rate in HIV-infected patients. Effects on HIV-1 viral load.

Rey D, Krantz V, Partisani M, Schmitt MP, Meyer P, Libbrecht E, Wendling MJ, Vetter D, Nicolle M, Kempf-Durepaire G, Lang JM.

Vaccine. 2000 Jan 18;18(13):1161-5.


Supplemental Content

Support Center